tiprankstipranks
Novo Nordisk (NVO)
:NVO
US Market
Holding NVO?
Track your performance easily

Novo Nordisk (NVO) Financial Statements

7,748 Followers

Novo Nordisk Financial Overview

Novo Nordisk's market cap is currently ―. The company's EPS TTM is $3.09; its P/E ratio is ―; and it has a dividend yield of 1.23%. Novo Nordisk is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $0.84. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 65.86B$ 53.37B$ 48.09B$ 45.57B$ 41.27B
Gross Profit$ 55.85B$ 45.19B$ 39.83B$ 38.37B$ 35.20B
EBIT-----
EBITDA-----
Net Income Common Stockholders$ 21.96B$ 19.81B$ 13.59B$ 14.40B$ 13.32B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.23B$ 27.77B$ 23.57B$ 37.47B$ 31.04B
Total Assets$ 314.49B$ 250.03B$ 241.26B$ 242.84B$ 218.93B
Total Debt$ ―$ 25.52B$ 50.10B$ 25.97B$ 25.43B
Net Debt$ ―$ -2.25B$ 26.53B$ -11.50B$ -5.60B
Total Liabilities$ 377.58B$ 170.15B$ 278.71B$ 166.16B$ 144.48B
Stockholders Equity$ 106.56B$ 79.87B$ 83.49B$ 76.68B$ 74.45B
Cash Flow-
Free Cash Flow$ -6.88B$ 25.01B$ -19.95B$ 63.21B-
Operating Cash Flow$ 9.55B$ 29.81B$ -13.78B$ 71.79B-
Investing Cash Flow$ -14.72B$ -6.65B$ -13.85B$ -11.07B-
Financing Cash Flow$ -10.12B$ -20.62B$ -7.67B$ -44.13B-
Currency in USD

Novo Nordisk Earnings and Revenue History

Novo Nordisk Debt to Assets

Novo Nordisk Cash Flow

Novo Nordisk Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis